Article

Winners of ARVO/Pfizer translational research awards announced

Joan W. Miller, MD, and Joel S. Schuman, MD, are the winners of the2006 ARVO/Pfizer Ophthalmics Translational Research Awards.

Joan W. Miller, MD, and Joel S. Schuman, MD, are the winners of the 2006 ARVO/Pfizer Ophthalmics Translational Research Awards.

Dr. Miller, of the Massachusetts Eye and Ear Infirmary, Boston, was honored for research in non-human primates and resulting translation to humans. This led to the development of photodynamic therapy of neovascular age-related macular degeneration.

Dr. Schuman, University of Pittsburgh, was recognized as a key researcher in the development of optical coherence tomography, which has widespread clinical application in the diagnosis and management of glaucoma and retinal diseases.

The awards were established with the intent of honoring excellence in research and fundamental scientific discoveries, concepts, and novel technologies that lead to clinical evidence of diagnosis, prevention, or amelioration of the pathological eye and/or understanding of normal vision processes. The translational research awards are made possible through a grant from Pfizer Ophthalmics to The ARVO Foundation for Eye Research.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.